AI assistant
Egetis Therapeutics Major Shareholding Notification 2023
3152_iss_2023-11-01_65131d0a-7056-402b-9caa-2929ae865e53.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Egetis Therapeutics AB (publ)
Holder
Flerie Invest AB
Instrument
| Aktier SE0003815604 | |
|---|---|
| 13,844,458 | |
| 13,844,458 | |
| Reason for major shareholding notification Corporate action | |
| 31/10/2023 | |
| 5 % | |
| 5 % | |
| 13,844,458 | |
| 13,844,458 | |
| 0 | |
| 4.73199 % | |
| 4.73199 % | |
| 0 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.73199 % | 13,844,458 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.73199 % | 13,844,458 |
| Group total holdings |
||
| Voting rights 13,844,458 |
||
| Percentage of voting rights 4.73199 | ||
| Published | ||
| 01/11/2023 09:13 | ||
| Contact | ||
| Name Cecilia Schéele |
||
| Phone 0706006856 |
Email [email protected] | |
| CLOSE |
||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25